PDII Lower on Expected Reductions from AstraZeneca
Tweet Send to a Friend
PDI, Inc. (Nasdaq: PDII) is under heavy pressure this morning (-16.8%) after the company disclosed it ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


